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Abstract
Introduction: Preanalytical errors, along the process from the beginning of test requests to the admissions of the specimens to the laboratory, 
cause the rejection of samples. The aim of this study was to better explain the reasons of rejected samples, regarding to their rates in certain test 
groups in our laboratory.
Materials and methods: This preliminary study was designed on the rejected samples in one-year period, based on the rates and types of ina-
ppropriateness. Test requests and blood samples of clinical chemistry, immunoassay, hematology, glycated hemoglobin, coagulation and erythro-
cyte sedimentation rate test units were evaluated. Types of inappropriateness were evaluated as follows: improperly labelled samples, hemolysed, 
clotted specimen, insufficient volume of specimen and total request errors.
Results: A total of 5,183,582 test requests from 1,035,743 blood collection tubes were considered. The total rejection rate was 0.65 %. The rejection 
rate of coagulation group was significantly higher (2.28%) than the other test groups (P < 0.001) including insufficient volume of specimen error 
rate as 1.38%. Rejection rates of hemolysis, clotted specimen and insufficient volume of sample error were found to be 8%, 24% and 34%, respecti-
vely. Total request errors, particularly, for unintelligible requests were 32% of the total for inpatients.
Conclusions: The errors were especially attributable to unintelligible requests of inappropriate test requests, improperly labelled samples for inpa-
tients and blood drawing errors especially due to insufficient volume of specimens in a coagulation test group. Further studies should be performed 
after corrective and preventive actions to detect a possible decrease in rejecting samples.
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Collecting and analyzing data consistently are nec-
essary tasks for assessing quality, monitoring 
standardized key processes, improving perform-
ance and patient safety in clinical laboratories. 
These influences 70% of medical diagnoses (1,2). 
Laboratory testing, commonly known as total test-
ing process (TTP), is generally subdivided as pre-
analytical, analytical and postanalytical phases 
(3,4). Preanalytical phase errors have been found 
at the majority of the total errors (46-68.2%) in lab-
oratory and research medicine (5). Unfortunately, 
according to the literature which comprises the 
process from the beginning of laboratory test re-
quests to the delivery of specimens in the labora-
tory, there is no sufficient data on errors during the 
initial steps of preanalytical phase (6). However, 
the error magnitude depends on the capacity of a 
system of error reporting.
Data on rejected samples due to various types of 
preanalytical errors is one of the laboratory medi-
cine preanalytical quality indicators. There is a set 
of significant data including various types of errors 
such as the appropriateness of test order, patient 
wristband identification error, timing errors in sam-
pling and preparation, hemolytic, lipemic blood 
samples and inappropriate transport, inadequate 
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and inappropriate tubes portion of the sample 
(2,7-10). However, the types of error in the preana-
lytical phase seem to have changed over time, but 
distribution of errors among other phases of TTP 
has remained the same (11).
Poor communications among physicians, nurses 
and phlebotomists involved in the TTP or poorly 
designed processes are also counted as laboratory 
errors in preanalytical phase (5).
Preanalytical phase errors start to occur at the 
point of entry for laboratory test requests by clini-
cians. Rejection reasons of test requests generally 
include requests for wrong tests, missing input of 
tests, ordering a medically unnecessary tests, over-
ordering, erroneous coding or unintelligible re-
quests. In some conditions, test requests were re-
jected with the whole test panel, while only a few 
tests were selected to be rejected within the clini-
cians’ request panel. For example: hemolysis inter-
ference, one of the most common reasons, espe-
cially affects lactate dehydrogenase, aspartate 
aminotransferase, potassium and total bilirubin 
concentration, while other tests are not interfered, 
since it is possible to perform measurement until a 
severe level of hemolysis (7). Additionally, if test re-
quests cannot appropriate for calculating, these 
tests are obliged to rejection.
Personal impact on specimen collection is impor-
tant factor and the preanalytical error rate is 2 to 4 
times higher for non-laboratory phlebotomists 
than laboratory staff (9). Inappropriateness of the 
samples especially due to blood drawing errors 
generally occurs when the blood samples are 
drawn by nurses whose experiences and training 
are not sufficient for blood drawing in clinics com-
paring to the phlebotomists who are a group of 
more stable staff.
The reasons for rejection and their high-level rates 
might gather into certain tests due to the unique 
operating characteristics of the test groups during 
routine work. The aim of this study was to better 
explain the rates and reasons of rejected samples, 
regarding to the certain test groups in our labora-
tory. Their respective rates might provide aid for 
the planning of the preventive and corrective op-




Izmir Ataturk Training and Research Hospital, affili-
ated with Katip Celebi University Medical School, 
is an approximately 1,100- bed tertiary care center 
that serves the Aegean Region of Turkey. It is certi-
fied with TS EN ISO 9001:2008 standards by Turkish 
Standards Institution that is a member of the Inter-
national Organization for Standardization (ISO). 
Additionally, the Health Service Quality Standards 
criteria which had been prepared in consideration 
with international practices, expertise ideas, strat-
egies and objectives of the Ministry of Health of 
the Republic of Turkey are applied in our laborato-
ry. Our laboratory serves to inpatients, outpatients 
and emergency department.
Study design
We performed this study in the time period be-
tween February 1, 2012, and January 31, 2013. The 
six types of laboratory test groups was included: 
clinical chemistry (3 analyzers: Abbott Architect 
C-16000; 35 tests such as metabolites, enzymes, 
electrolytes, lipids etc. included); immunoassays (3 
analyzers: Siemens, Advia Centaur XP; 29 tests such 
as thyroid function tests, fertility hormones, tumor 
markers etc.); hematology (3 analyzers: Mindray BC 
6800; 22 parameters); glycated hemoglobin (HbA1c) 
(1 analyzer: Adams HA-8180V); coagulation (2 ana-
lyzers: ACL TOP 700; 14 tests such as factors, pro-
thrombine time, fibrinogen, D-Dimer etc.) and 
erythrocyte sedimentation rate (ESR) (2 analyzers: 
Vacuplus ESR-120), excluding emergency unit 
data.
This study was a descriptive preliminary study 
which inappropriateness of samples and test re-
quests were observed. It was designed according 
to the number of the samples and types of errors 
for each test group that were previously ex-
plained.
The path of the samples
Since there could be problems in the labelling and 
drawing of the samples, it was necessary to exam-
ine how the system worked. Bar-coding identifica-
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tion technology was used in our hospital. A clini-
cian requested tests electronically for a patient in 
the hospital information system. For inpatients, 
phelobotomist picked up the requisition and gen-
erated barcode labels from the system, properly 
sticked on pertinent tubes and went to the bed-
side to check patient’s identification. For outpa-
tients, this procedure was as follows: patient re-
ceived the appropriate tubes with the barcodes 
from the staff and gave them to the phlebotomist.
Sample collection tubes
Samples are drawn by routine venipuncture using 
the order of blood draw as suggested by the Clini-
cal and Laboratory Standards Institute (12).
In this study, Na-citrate vacutainer tubes for coag-
ulation tests and ESR, tubes with gel separator for 
clinical chemistry and immunoassay tests and 
K2EDTA tubes for hematology and HbA1c (Becton 
Dickinson and Company, USA) were used. Then, 
the specimens were transferred to the laboratory 
by the trained staff for processing. At the time of 
sample receipt, technicians visually checked the 
samples with regard to volume, label, clot and si-
multaneously matched label with those on the ac-
companying requisition form and accepted ac-
cordingly.
Any inappropriateness was recorded in laboratory 
information system. The specimens were allowed 
to clot, centrifuged at 1500 x g for 10 minutes and 
then delivered to the analyzers.
Methods
Monthly total data were obtained from laboratory 
and hospital information systems. This was our 
routine work of quality process monitoring as a 
proposal of the Ministry of Health of the Republic 
of Turkey. Then, twelve one-month data were 
present. Percentage calculations were obtained by 
‘number of rejected samples’/ ‘total number of 
samples’ formula for each laboratory test unit.
This report was created by the hospital informa-
tion system (HIS) using Probel Computer Software 
Hardware Co. (Probel Bilgisayar Donanım Şirketi) 
(Version 1.0, Izmir, Turkey), extracting data from 
the laboratory information system (ALIS) using an 
Oracle database. Unfortunately, the only clinical 
chemistry unit was examined in relation to the sta-
tus of the patient (inpatient vs. outpatient), be-
cause we were constrained to obtain other test 
group data without separating each other due to 
measuring specimens by the same analyzer.
Types of inappropriateness
They were evaluated in five groups as follows: to-
tal request errors, improperly labelled samples, 
hemolysed specimen, clotted specimen and insuf-
ficient volume of specimens.
Total request error data were obtained from miss-
ing the input of tests, unintelligible requests and 
erroneous coding.
Missing input of tests implied that missing out on 
ordering the right test. The requests for certain 
tests (such as LDL cholesterol, globulin, indirect bi-
lirubin, total iron binding capacity) that were nec-
essary to calculate related tests’ concentrations 
were missing, therefore they could not be calculat-
ed for the specimen.
Biochemical properties, half-lives and clinical utili-
ty of biochemical tests were useful to evaluate the 
time frame for unintelligible requests. The only 
HbA1c test request was automatically limited with-
in 3 months by HIS in our hospital. Then, laborato-
ry staff recorded the test requests that clinician ac-
cidentally requested same parameter twice for the 
same specimen of the same patient, or two clini-
cians from different departments requested same 
parameter within the last 4 hours of the current 
date as unintelligible requests (except HbA1c).
Erroneous coding errors implied that over-order-
ing of tests or the absence of the specimen while 
the coding of tests somehow existed in the hospi-
tal information system.
Improperly labelled samples were comprised mis-
labelled or unlabeled samples. If the label did not 
match the test requisition or if the sample was be-
longed to a different patient, this situation was 
considered as misidentification of patient and the 
sample was recorded as mislabelled, while speci-
men with no label was recorded as unlabeled. Ad-
ditionally, the error of swapping the urine and 
blood sample labels that belonged to the same 
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patient was detected as one of the labelling error 
according to the feedback from laboratory staff.
Mishandling of specimen caused hemolysed, clot-
ted and insufficient volume of specimens. These 
blood drawing errors were visually detected by 
technicians. If there were not any severe changes 
in colour of the serum, these samples were not re-
jected, whereas mild colour changes cause rejec-
tion of some tests and dark colour causes sample 
rejection in our laboratory. If there was any clot in 
the sample or the sample volume was not enough 
for studying the all tests (mistakes in tube filling, 
especially, for plasma–citrated samples), these 
were also rejected.
Statistical analysis
Calculations of rejected specimens for each test 
group were presented as rate, rate ratios, and per-
centages. Statistical package for Windows, Version 
15.0, SPSS Inc. (Chicago, IL, USA) was used for sta-
tistical analysis. The distribution of the ratios for 12 
one-month periods was determined using the 
Shapiro-Wilk normality test. The significant differ-
ences of the total rejection rates among test 
groups were determined by nonparametric Kruskal 
Wallis test. The significant differences of various 
types of errors were determined by paired sam-
ples t-test for each test group. P value < 0.05 was 
considered statistically significant for multiple 
comparisons.
Results
During the 1 year period, a total of 5,183,582 test 
requests from 1,035,743 blood collection tubes 
were considered. The total rejection rate for all 
samples was 0.65% (6,775 / 1,035,743). The total 
number of samples and the rejection rates of each 
laboratory test unit are shown in Figure 1. The re-
jection rate of coagulation group was significantly 
higher than the other test groups (P < 0.001). The 
specimen rejection ratio was 16.5 times higher in 
inpatients than outpatients for routine clinical 
chemistry test group including all types of errors 
(2.64% vs. 0.16%, respectively).
Specimen rejection rates according to the four out 
of five error reasons of laboratory test groups were 
presented in Table 1. Rejection rates due to inap-
propriate test requests were shown in Table 2.
Although improperly labelled samples are not com-
mon, inadequate specimen labelling information in 
clinical chemistry was observed with the highest ra-
tio in hospitalized patients in this study (P = 0.027).
Rejection rates of blood drawing errors that were 
hemolysis, clotted specimen and insufficient vol-
ume of specimens were found to be 8%, 24% and 
34%, respectively among all rejected samples in 
the study. Hemolysis affected the specimens of in-
patients in clinical chemistry and coagulation test 
groups. The clotted specimen error was seen in 
ESR, coagulation and hematology. Insufficient vol-
ume of specimen error in coagulation was found 
Figure 1. Total number of the samples and rejection rates of each laboratory test units (%). Percentages were calculated as ‘number 
of rejected samples’/ total number of samples’ of each laboratory test unit. Bars represent actual laboratory data for a 1 year period.
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Laboratory test 
groups






Total request error 
(%)
Clinical chemistry inpatient 0.84 2.43* 1.80 1.69**
Clinical chemistry outpatient 0.01 0.01 0.02 0.01
Immunoassay 0.00 0.01 0.02 0.01
Coagulation 0.01 0.02 0.04 0.03
Percentages were calculated by ‘number of rejected samples’/ total number of samples’ of each laboratory test unit for a 1 year 
period. *P < 0.001 among other errors, **P<0.001 among both other test groups and other errors.
ESR - erythrocyte sedimentation rate.











Clinical chemistry inpatient 0.03* 0.06 0 0.01
Clinical chemistry outpatient 0 0 - 0
Immunoassay 0 0 - 0.10
Coagulation 0.02 0.48 0.26 1.38**
HbA1c 0.01 - 0.01 0.01
Hematology 0.01 - 0.16* 0.02
ESR 0.01 - 0.64* 0.25
Percentages were calculated by ‘number of rejected samples’/ total number of samples’ of each laboratory test unit for a 1 year 
period. *P=0.027 among other test groups, **P < 0.001 among other error reasons.
ESR - erythrocyte sedimentation rate.
Table 1. Specimen rejection rates according to the error reasons.
as the most common rejection cause among other 
types of errors in our study (P < 0.001). Plasma–cit-
rated samples were used to study for coagulation 
and ESR groups and exhibited the highest percent-
age of rejection rate of blood drawing errors (71% 
of the total rejection number of all test groups), 
whereas the lowest rate had corresponded to se-
rum samples in clinical chemistry and immu-
noassay tests (10%). The whole blood-EDTA sam-
ples in HbA1c and hematology tests’ ratio was 17%.
In inpatient clinical chemistry groups, total request 
error rates showed the highest rate both among 
the other test groups and other causes (P < 0.001). 
In this group, ‘total request errors /total request er-
rors of all test groups’ ratio was 82% and unintelli-
gible requests were found as the most common 
rejection cause of the test requests (P < 0.001). Ad-
ditionally, total request errors were 32% of total re-
jection number [(total number of request errors / 
total number of rejections) x 100] according to our 
study of inpatient clinical chemistry.
Discussion
Among the patient specimens included for a one 
year period in our study, the rejection rate of co-
agulation unit had the maximum sample rejection, 
especially due to insufficient volume of specimen 
error as the most common rejection cause. Addi-
tionally, missing the input of tests, unintelligible 
requests and erroneous coding were commonly 
seen as inappropriate test requests in inpatient 
group.
The majority of the total testing process errors is 
caused by personal and system-based defects in 
the preanalytical phase. The development of pro-
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cedures, training, interdepartmental communica-
tion, information technology, and robotics can re-
duce these errors (3).
Simundic et al. recently reported, in parallel to our 
study, that the sample error rate differed signifi-
cantly with respect to the laboratory unit and pa-
tient application site (inpatient or outpatient) and 
the test request errors were most frequent in inpa-
tient routine biochemistry unit (65%) (13).
Carraro et al. performed the study and revealed 
that the frequency of errors regarding order trans-
mission and hemolysed samples in the preanalyti-
cal phase were high. They also concluded that pa-
tient misidentification including test requests 
without patient’s name and failure to check the 
identity during drawing blood were frequently ob-
served (6).
In the preliminary study on quality indicators, er-
ror rates in preanalytical indicators such as errone-
ous request, erroneous sample, and samples that 
were not taken were found as 4.1%, 5% and 1.7%, 
respectively (14).
Ricos et al. reported that error in patient identifica-
tion during ordering process was 0.08%, incorrect 
request was 0.1%, lack of collection together with 
the request in the sampling phase was 7%, re-
draws were 2%, inconvenient transport conditions 
were 0.005%, hemolysed samples were 0.2% (15).
In an overview of the results of 4 years of the pre-
analytical quality control program, the total rejec-
tion rate of samples was 0.69%. In the same study, 
29% of all rejections were due to hemolysis and 
14% to clotted sample. Similar to our study, plas-
ma–citrated samples showed the highest percent-
age of rejection (1.47%) and the lowest rate was in 
whole blood-EDTA samples (0.38%) (16).
Comparably to present study, errors of labelling 
samples using for patient and specimen identifica-
tion have been reported between 0.01% and 
0.03% for clinical chemistry and hematology speci-
men by the Q-Probes study of the College of 
American Pathologists (17). The sample rejection 
rate had been reported ranging from 0.3% to 0.8% 
in data from multi-center quality monitoring pro-
grams (18). Although it was not common, we ob-
served that patients’ labels were changed to each 
other especially in inpatient specimens. In routine 
work, printing labels of several patients in the se-
ries were prone to more errors. To avoid from these 
errors, tube barcodes for each patient should have 
been individually printed and immediately sticked 
on to the tube. Also, standardized patient label in-
formation is very important to decrease errors and 
to avoid from inaccurate or inadequate informa-
tion (19). Moreover, delta check is a warning factor 
for technicians and useful for detecting the misi-
dentification of patients. The urine concentrations 
were used for some clinical chemistry calculating 
tests (creatinine clearance etc.). However, phlebot-
omists accidentally swapped blood and urine bar-
codes and caused to the rejection of samples as an 
improper labelling error.
Most of human dependent and preventable pre-
analytical errors have occurred during sample 
drawing. Plasma–citrated samples were especially 
exhibited the highest percentage of rejection rate 
of blood drawing errors. Coagulation tubes were 
used in first order of blood draw and more vulner-
able to inappropriate mixing and fulfilling of tubes 
causing to clotted and insufficient volume of spec-
imen errors. These non-conformities could be pre-
vented by phlebotomists’ training.
One of the limitations of our study was that we 
could only give the results of inpatients for clinical 
chemistry test group, but not others. Because we 
have used the analyzers without sample separa-
tion according to inpatient or outpatient for the 
other test groups, we could not give data. Another 
limitation was that we did not detect and reject 
test requests which were ordering a medically un-
necessary test.
Since 2007, increasing use of automation systems 
for preanalytical phase also has helped to reduce 
errors. Because of the rejection of specimen has an 
effect on repeat behaviour, delay in reporting and 
finally, missed diagnosis and unnecessary costs, 
using available published guidelines for a variety 
of clinical situations and various diseases for 
screening, diagnosis and treatment to select ap-
propriate tests with respect to the clinical question 
as a quality indicator is recommended. Improving 
cooperation with clinicians and giving advice on 
test selections will be useful to prevent from unin-
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telligible requests and input of added or missing 
tests (20). Efficient use of health information tech-
nology, good laboratory practices, provision of ed-
ucation, feedback, electronic decision- support 
systems and reminders to clinicians and revisions 
in requisition forms can contribute to this process 
and then, will also provide opportunities for cor-
rective actions.
In conclusion, higher ratios of errors were especial-
ly attributable to unintelligible requests in inap-
propriate test requests and improperly labelled 
samples for inpatient group and blood drawing 
errors especially due to insufficient volume of 
specimens in a coagulation test group. The efforts 
aimed to reduce the rates of rejected samples can 
provide to improve the quality of laboratory based 
health care processes. Further studies should be 
performed after corrective and preventive actions 
for rejecting samples.
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